Abonnement à la biblothèque: Guest
Critical Reviews™ in Oncogenesis

Publication de 4  numéros par an

ISSN Imprimer: 0893-9675

ISSN En ligne: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Counteracting Inflammation: A Promising Therapy in Cachexia

Volume 17, Numéro 3, 2012, pp. 253-262
DOI: 10.1615/CritRevOncog.v17.i3.30
Get accessGet access

RÉSUMÉ

Disease progression in cancer is dependent on the complex interaction between the tumor and the host inflammatory response. Indeed, both the tumor and the patient produce cytokines that act on multiple target sites such as bone marrow, myocytes, hepatocytes, adipocytes, endothelial cells, and neurons, where they produce a complex cascade of biological responses leading to the wasting associated with cachexia. The cytokines that have been involved in this cachectic response are TNF-α, IL-1, IL-6, and interferon-gamma. Interestingly, these cytokines share the same metabolic effects, and their activities are closely interrelated. In many cases these cytokines exhibit synergic effects when administered together. Therefore, therapeutic strategies− either nutritional or pharmacological−have been based on either blocking their synthesis or their action.

CITÉ PAR
  1. Tuca Albert, Jimenez-Fonseca Paula, Gascón Pere, Clinical evaluation and optimal management of cancer cachexia, Critical Reviews in Oncology/Hematology, 88, 3, 2013. Crossref

  2. Puig L., Anti-tumour necrosis factor-α treatment and weight gain in psoriasis: the ‘pudgy blanching’ conundrum, British Journal of Dermatology, 168, 5, 2013. Crossref

  3. Argilés Josep M., Busquets Sílvia, Stemmler Britta, López-Soriano Francisco J., Cancer cachexia: understanding the molecular basis, Nature Reviews Cancer, 14, 11, 2014. Crossref

  4. Al-Mutairi Nawaf, Nour Tarek, The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial, Expert Opinion on Biological Therapy, 14, 6, 2014. Crossref

  5. Mesa Ruben A., Verstovsek Srdan, Gupta Vikas, Mascarenhas John O., Atallah Ehab, Burn Timothy, Sun William, Sandor Victor, Gotlib Jason, Effects of Ruxolitinib Treatment on Metabolic and Nutritional Parameters in Patients With Myelofibrosis From COMFORT-I, Clinical Lymphoma Myeloma and Leukemia, 15, 4, 2015. Crossref

  6. Inácio Pinto Nelson, Carnier June, Oyama Lila M., Otoch Jose Pinhata, Alcântara Paulo Sergio, Tokeshi Flavio, Nascimento Claudia M., Cancer as a Proinflammatory Environment: Metastasis and Cachexia, Mediators of Inflammation, 2015, 2015. Crossref

  7. Ebadi Maryam, Mazurak Vera C., Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia, Mediators of Inflammation, 2015, 2015. Crossref

  8. Shaukat Zeeshan, Liu Dawei, Gregory Stephen, Sterile Inflammation inDrosophila, Mediators of Inflammation, 2015, 2015. Crossref

  9. Fielitz Jens, Cancer cachexia—when proteasomal inhibition is not enough, Journal of Cachexia, Sarcopenia and Muscle, 7, 3, 2016. Crossref

  10. Fukushima Hiroshi, Nakanishi Yasukazu, Kataoka Madoka, Tobisu Ken‐ichi, Koga Fumitaka, Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy, Cancer Medicine, 5, 9, 2016. Crossref

  11. Porporato P E, Understanding cachexia as a cancer metabolism syndrome, Oncogenesis, 5, 2, 2016. Crossref

  12. Kim Jin-Min, Sung Mi-Kyung, The Efficacy of Oral Nutritional Intervention in Malnourished Cancer Patients: a Systemic Review, Clinical Nutrition Research, 5, 4, 2016. Crossref

  13. Toneto Aline Tatiane, Ferreira Ramos Luiz Alberto, Salomão Emilianne Miguel, Tomasin Rebeka, Aereas Miguel Arcanjo, Gomes-Marcondes Maria Cristina Cintra, Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals, Journal of Cachexia, Sarcopenia and Muscle, 7, 5, 2016. Crossref

  14. Argilés Josep M., The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer, Clinical Nutrition, 36, 3, 2017. Crossref

  15. Bove R., Musallam A., Xia Z., Baruch N., Messina S., Healy B.C., Chitnis T., Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity, Multiple Sclerosis and Related Disorders, 8, 2016. Crossref

  16. Miyake Makito, Morizawa Yosuke, Hori Shunta, Marugami Nagaaki, Shimada Keiji, Gotoh Daisuke, Tatsumi Yoshihiro, Nakai Yasushi, Inoue Takeshi, Anai Satoshi, Torimoto Kazumasa, Aoki Katsuya, Tanaka Nobumichi, Fujimoto Kiyohide, Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder, BMC Cancer, 17, 1, 2017. Crossref

  17. Fukushima Hiroshi, Yokoyama Minato, Nakanishi Yasukazu, Tobisu Ken-ichi, Koga Fumitaka, Tagliabue Elda, Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma, PLOS ONE, 10, 1, 2015. Crossref

  18. Zhang Guohua, Liu Zhelong, Ding Hui, Miao Hongyu, Garcia Jose M., Li Yi-Ping, Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways, Scientific Reports, 7, 1, 2017. Crossref

  19. Ellis J., Porcine Circovirus, Veterinary Pathology, 51, 2, 2014. Crossref

  20. Hardee Justin P., Counts Brittany R., Carson James A., Understanding the Role of Exercise in Cancer Cachexia Therapy, American Journal of Lifestyle Medicine, 13, 1, 2019. Crossref

  21. Argilés Josep M., Stemmler Britta, López-Soriano Francisco J., Busquets Silvia, Inter-tissue communication in cancer cachexia, Nature Reviews Endocrinology, 15, 1, 2019. Crossref

  22. Donma Mustafa Metin, Donma Orkide, Asprosin: Possible target in connection with ghrelin and cytokine network expression in the post-burn treatment, Medical Hypotheses, 118, 2018. Crossref

  23. Lai Shaoqing, Cancer related fatigue and cancer cachexia are the consequence of endocrine failure caused by persistent stress, Medical Hypotheses, 123, 2019. Crossref

  24. Kasembeli Moses, Bharadwaj Uddalak, Robinson Prema, Tweardy David, Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment, International Journal of Molecular Sciences, 19, 8, 2018. Crossref

  25. Argilés Josep M., Busquets Sílvia, López-Soriano Francisco Javier, Cancer cachexia, a clinical challenge, Current Opinion in Oncology, 31, 4, 2019. Crossref

  26. Ebadi Maryam, Bhanji Rahima A., Mazurak Vera C., Montano-Loza Aldo J., Sarcopenia in cirrhosis: from pathogenesis to interventions, Journal of Gastroenterology, 54, 10, 2019. Crossref

  27. Freire Paula Paccielli, Fernandez Geysson Javier, Cury Sarah Santiloni, de Moraes Diogo, Oliveira Jakeline Santos, de Oliveira Grasieli, Dal-Pai-Silva Maeli, dos Reis Patrícia Pintor, Carvalho Robson Francisco, The Pathway to Cancer Cachexia: MicroRNA-Regulated Networks in Muscle Wasting Based on Integrative Meta-Analysis, International Journal of Molecular Sciences, 20, 8, 2019. Crossref

  28. Köstek Osman, Yılmaz Erdem, Hacıoğlu Muhammet Bekir, Demircan Nazım Can, Gökyer Ali, Uzunoğlu Sernaz, Tunçbilek Nermin, Çiçin İrfan, Erdoğan Bülent, Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer, Cancer Chemotherapy and Pharmacology, 83, 4, 2019. Crossref

  29. Argilés Josep M., López-Soriano Francisco J., Busquets Silvia, Mediators of cachexia in cancer patients, Nutrition, 66, 2019. Crossref

  30. Hsu Myriam Y., Porporato Paolo E., Wyart Elisabeth, Assessing Metabolic Dysregulation in Muscle During Cachexia, in Cancer Metabolism, 1928, 2019. Crossref

  31. Ferrara Michele, Chialli Ginevra, Ferreira Lorena Maria, Ruggieri Elena, Careccia Giorgia, Preti Alessandro, Piccirillo Rosanna, Bianchi Marco Emilio, Sitia Giovanni, Venereau Emilie, Oxidation of HMGB1 Is a Dynamically Regulated Process in Physiological and Pathological Conditions, Frontiers in Immunology, 11, 2020. Crossref

  32. Guo Zhenlang, Gu Chiming, Gan Shu, Li Yuan, Xiang Songtao, Gong Leiliang, Chan Franky Leung, Wang Shusheng, Sarcopenia as a predictor of postoperative outcomes after urologic oncology surgery: A systematic review and meta-analysis, Urologic Oncology: Seminars and Original Investigations, 38, 6, 2020. Crossref

  33. Peixoto da Silva Sara, Santos Joana M.O., Costa e Silva Maria Paula, Gil da Costa Rui M., Medeiros Rui, Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia, Journal of Cachexia, Sarcopenia and Muscle, 11, 3, 2020. Crossref

  34. Morimoto Megumi , Aikawa Katsuji , Hara Takahito , Yamaoka Masuo , Prevention of body weight loss and sarcopenia by a novel selective androgen receptor modulator in cancer cachexia models, Oncology Letters, 2017. Crossref

  35. Njunge James M., Gonzales Gerard Bryan, Ngari Moses M., Thitiri Johnstone, Bandsma Robert H.J., Berkley James A., Systemic inflammation is negatively associated with early post discharge growth following acute illness among severely malnourished children - a pilot study, Wellcome Open Research, 5, 2020. Crossref

  36. Wyart Elisabeth, Bindels Laure B., Mina Erica, Menga Alessio, Stanga Serena, Porporato Paolo E., Cachexia, a Systemic Disease beyond Muscle Atrophy, International Journal of Molecular Sciences, 21, 22, 2020. Crossref

  37. Leal Luana G., Lopes Magno A., Peres Sidney B., Batista Miguel L., Exercise Training as Therapeutic Approach in Cancer Cachexia: A Review of Potential Anti-inflammatory Effect on Muscle Wasting, Frontiers in Physiology, 11, 2021. Crossref

  38. Njunge James M., Gonzales Gerard Bryan, Ngari Moses M., Thitiri Johnstone, Bandsma Robert H.J., Berkley James A., Systemic inflammation is negatively associated with early post discharge growth following acute illness among severely malnourished children - a pilot study, Wellcome Open Research, 5, 2021. Crossref

  39. Fatima Kaneez, Andleeb Asifa, Hussain Imtiyaz, Sofi MushtaqAhmed, Fir Afroz, Qadri SumyraKhurshid, Megestrol acetate in cancer cachexia and anorexia: Tertiary care experience, Journal of Radiation and Cancer Research, 12, 4, 2021. Crossref

  40. Kasprzak Aldona, The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia, International Journal of Molecular Sciences, 22, 4, 2021. Crossref

  41. Gurovich Alvaro N., Tiwari Sangeeta, Kehl Stephanie, Umucu Emre, Peñailillo Luis, A Novel “Eccentric” Therapeutic Approach for Individuals Recovering From COVID-19, Cardiopulmonary Physical Therapy Journal, 32, 1, 2021. Crossref

  42. Wang Dexing, Duan Li, Tu Zhiquan, Yan Fei, Zhang Cuicui, Li Xu, Cao Yuzhu, Wen Hongsheng, The Glasgow Prognostic Score Predicts Response to Chemotherapy in Patients with Metastatic Breast Cancer, Chemotherapy, 61, 4, 2016. Crossref

  43. Wen Hong-Sheng, Li Xu, Cao Yu-Zhu, Zhang Cui-Cui, Yang Fang, Shi Yu-Ming, Peng Li-Ming, Clinical Studies on the Treatment of Cancer Cachexia with Megestrol Acetate plus Thalidomide, Chemotherapy, 58, 6, 2012. Crossref

  44. Aziz Mohammad Hosein, van Dongen Jelle C., Saida Lawlaw, Suker Mustafa, van Vugt Jeroen L. A., van Putten Yordi, Sideras Kostandinos, Groen Jesse V., Mieog J. Sven D., Lucassen Claudia J., Droop Anneke, Mauff Katya, Shahbazi Feshtali Shirin, Groot Koerkamp Bas, Mustafa Dana A. M., van Eijck Casper J., High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma, Frontiers in Oncology, 12, 2022. Crossref

  45. Fakhri Sajad, Piri Sana, Khan Haroon, Cachexia and phytonutrients, in The Role of Phytonutrients in Metabolic Disorders, 2022. Crossref

  46. Bordignon Cláudia, dos Santos Bethânia S., Rosa Daniela D., Impact of Cancer Cachexia on Cardiac and Skeletal Muscle: Role of Exercise Training, Cancers, 14, 2, 2022. Crossref

  47. Ruan Guo-Tian, Xie Hai-Lun, Zhang He-Yang, Liu Chen-An, Ge Yi-Zhong, Zhang Qi, Wang Zi-Wen, Zhang Xi, Tang Meng, Song Meng-Meng, Zhang Xiao-Wei, Yang Ming, Chen Yong-Bing, Yu Kai-Ying, Deng Li, Gong Yi-Zhen, Hu Wen, Wang Kun-Hua, Cong Ming-Hua, Shi Han-Ping, A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer, Frontiers in Endocrinology, 13, 2022. Crossref

  48. Zhang Beiying, Bi Qianyu, Huang Shengqi, Lv Siyuan, Zong Xin, Wang Mengran, Ji Xuming, Baoyuan Jiedu decoction alleviating cancer cachexia–Induced muscle atrophy by regulating muscle mitochondrial function in ApcMin/+ mice, Frontiers in Pharmacology, 13, 2022. Crossref

  49. Jia Huijuan, Lyu Weida, Hirota Kazuki, Saito Eri, Miyoshi Moe, Hohjoh Hirohiko, Furukawa Kyohei, Saito Kenji, Haritani Makoto, Taguchi Akashi, Hasebe Yukio, Kato Hisanori, Eggshell membrane modulates gut microbiota to prevent murine pre‐cachexia through suppression of T helper cell differentiation, Journal of Cachexia, Sarcopenia and Muscle, 13, 4, 2022. Crossref

  50. Ferrara Michele, Samaden Maria, Ruggieri Elena, Vénéreau Emilie, Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene, Frontiers in Cell and Developmental Biology, 10, 2022. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain